United Therapeutics CorporationUTHRNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank29
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -3.69% |
| 2024 | 44.54% |
| 2023 | 12.64% |
| 2022 | 39.02% |
| 2021 | -31.45% |
| 2020 | 339.89% |
| 2019 | -148.87% |
| 2018 | 53.13% |
| 2017 | -35.39% |
| 2016 | 80.30% |